Molecular Detection of Resistance Genes and Mutations

Molecular detection of resistance identifies the genetic determinants of antimicrobial resistance directly, rather than inferring resistance from growth in the presence of drug. It includes targeted nucleic acid amplification of known resistance genes, detection of resistance-associated point mutations, and whole-genome sequencing that surveys the entire resistome.

Definition

Molecular detection of resistance is the use of nucleic acid amplification, hybridization, or sequencing to identify resistance genes, their mobile genetic contexts, or resistance-associated mutations in a microorganism, characterizing the genetic basis of resistance directly.

Scope

This entry covers targeted molecular assays for acquired resistance genes and for chromosomal resistance mutations, integrated rapid platforms used at the point of care or near it, and sequencing-based characterization with curated resistance-gene databases. It also addresses how genotype relates to phenotype. It is methodological reference material and does not give treatment guidance.

Core questions

• Which resistance genes or mutations does this organism carry?
• How do targeted assays, integrated rapid platforms, and whole-genome sequencing differ in scope and use?
• How well does a detected genotype predict the resistance phenotype?

Key concepts

• Acquired resistance genes and the resistome
• Resistance-associated point mutations (e.g. rpoB for rifampicin)
• Polymerase chain reaction (PCR) and nucleic acid amplification
• Integrated cartridge-based rapid platforms
• Whole-genome sequencing and resistance-gene databases
• Mobile genetic elements (plasmids, transposons, integrons)
• Genotype-phenotype prediction and discordance

Mechanisms

Targeted molecular assays amplify and detect specific resistance genes or mutations: nucleic acid amplification can identify acquired genes such as carbapenemase or methicillin-resistance determinants, or chromosomal mutations such as rpoB changes conferring rifampicin resistance in Mycobacterium tuberculosis (boehme-2010). Integrated cartridge-based platforms combine extraction, amplification, and detection to give rapid genotypic results from clinical specimens. Whole-genome sequencing surveys the complete set of resistance determinants, which are matched against curated databases of acquired resistance genes to predict resistance (zankari-2012; ellington-2017). Because many resistance genes reside on mobile genetic elements such as plasmids, transposons, and integrons, molecular methods also help characterize their genetic context and potential for spread (partridge-2018; strahilevitz-2009). Genotypic detection is rapid but does not always predict phenotype, since gene presence, expression, and additional mechanisms all contribute (ellington-2017).

Clinical relevance

Molecular detection supports rapid recognition of resistance determinants for surveillance, infection control, and stewardship, and can characterize outbreaks and transmission. This entry describes these methods as reference knowledge about how resistance is detected and characterized; it does not provide individual diagnostic or prescribing recommendations.

Epidemiology

Sequencing-based surveillance of resistance genes and their mobile elements has become central to tracking the emergence and international spread of resistance, linking isolates across settings and revealing the dissemination of plasmid-borne determinants (partridge-2018; strahilevitz-2009; ellington-2017).

History

Molecular detection of resistance grew from PCR-based assays for individual genes in the 1990s and 2000s to integrated rapid platforms and, increasingly, whole-genome sequencing. A landmark in clinical adoption was the automated cartridge assay for simultaneous detection of Mycobacterium tuberculosis and rifampicin resistance, which brought rapid genotypic resistance detection to routine practice (boehme-2010), while curated databases enabled systematic identification of acquired resistance genes from sequence data (zankari-2012).

Debates

Can sequencing replace phenotypic susceptibility testing?

Whole-genome sequencing can predict resistance for some organism-drug combinations but not reliably for all, because gene presence does not guarantee expression and not every mechanism is captured by current databases; how far genotype can substitute for phenotype is unresolved.

Interpreting genotype-phenotype discordance

Detected resistance genes are sometimes not phenotypically expressed, and resistant phenotypes sometimes lack a known genetic explanation, so reconciling molecular and phenotypic results remains a methodological challenge.

Seminal works

• boehme-2010
• zankari-2012
• ellington-2017

Frequently asked questions

What is the difference between detecting a resistance gene and measuring resistance?

Molecular methods detect the genetic determinant of resistance directly, while susceptibility testing measures whether the organism actually grows in the presence of the drug; a gene may be present without being expressed, so the two can disagree.

What can whole-genome sequencing add to resistance detection?

Sequencing can survey the entire set of resistance genes and mutations at once and characterize their mobile genetic context, supporting surveillance and outbreak investigation, though its prediction of phenotype is not yet reliable for every organism-drug combination.

Why are mobile genetic elements important in molecular detection?

Many resistance genes are carried on plasmids, transposons, and integrons that can move between bacteria, so detecting and characterizing these elements helps explain how resistance spreads.